Senior Associate Dean for Experimental and Cellular Therapeutics and
    Director of the Interdisciplinary Stem Cell Institute (ISCI)

    PROFESSOR JOSHUA M. HARE, MD, FACC is an internationally acknowledged pioneer in the field of stem cell therapeutics, currently seeing and evaluating patients from all over the world for this new experimental therapy. He is the senior associate dean for experimental and cellular therapeutics and director of the interdisciplinary item cell institute (ISCI), and Louis Lemberg Professor of Medicine at the University of Miami Miller School of Medicine. Professor Hare is also co-founder and chief science officer for Longeveron LLC, a regenerative medicine company based in Miami, Florida.

    Longeveron is developing biological solutions for aging and aging-associated diseases through the use of its proprietary mesenchymal stem cells, which are currently being evaluated under FDA-approved clinical trials in the U.S. and the Bahamas. Longeveron is currently conducting four clinical trials in the U.S. and an open-label clinical study registry in the Bahamas. Dr. Hare is an expert in cardiovascular medicine and specializes in heart failure, myocardial infarction, inflammatory diseases of the heart, and heart transplantation.


    Dr. Hare led the first randomized allogeneic mesenchymal stem cell (MSC) clinical trial for patients with myocardial infarction and is the principal investigator of multiple other trials for heart failure and cardiovascular disease. Dr. Hare has published more than 260 original research articles, editorials, and review articles, and is the recipient of seven grants from the National Institutes of Health. He holds 10 FDA Investigational New Drug applications for cell-based therapy, including the first in the United States for Idiopathic Pulmonary Fibrosis and Aging Frailty. He is the recipient of three active NIH RO1’s and is the PI of the UM National Heart Lung and Blood Institute Cardiac Cell Therapy Trial Network (CCTRN) center; together these awards fund ~$3M in basic and translational research annually. Educated at the University of Pennsylvania (1984), Johns Hopkins University School of Medicine (1988), The Brigham and Women's Hospital (1994), and Harvard Medical School, Dr. Hare spent 12 years on the faculty at Johns Hopkins University School of Medicine, where he rose to the rank of professor of medicine and biomedical engineering. He became the director of the cardiac transplant and heart failure program in 2004 before joining the faculty at the University of Miami Miller School of Medicine in 2007. Dr. Hare is an elected member of the American Association of Physicians (2011).